[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES8503677A1 - Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982). - Google Patents

Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982).

Info

Publication number
ES8503677A1
ES8503677A1 ES522869A ES522869A ES8503677A1 ES 8503677 A1 ES8503677 A1 ES 8503677A1 ES 522869 A ES522869 A ES 522869A ES 522869 A ES522869 A ES 522869A ES 8503677 A1 ES8503677 A1 ES 8503677A1
Authority
ES
Spain
Prior art keywords
etherified
substituted
optionally
unsubstituted
oxidized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522869A
Other languages
English (en)
Other versions
ES522869A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8503677A1 publication Critical patent/ES8503677A1/es
Publication of ES522869A0 publication Critical patent/ES522869A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE AZOLES 2,4,5-TRISUSTITUIDOS.CONSISTE EN TRATAR A UN COMPUESTO DE FORMULA (II) CON UNA BASE ORGANICA NITROGENADA, COMO BASES DE NITROGENO ORGANICAS TERCIARIAS Y BASES DE NITROGENO TERCIARIAS AROMATICAS, EN UN DISOLVENTE INERTE, A TEMPERATURA DE EBULLICION, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FARMACOLOGICAMENTE ACEPTABLES. SIENDO: R1 Y R2, INDEPENDIENTES ENTRE SI SIGNIFICAN RESTOS ARILOS INSUSTITUIDOS O SUSTITUIDOS POR RESTOS HIDROCARBUROS ALIFATICOS, HIDROXI LIBRE, ETERADO O ESTERIFICADO, MERCAPTO ETERADO Y OTROS.SE UTILIZAN COMO INHIBIDORES DE PROSTAGLANDINA.
ES522869A 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982). Granted ES522869A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH183881 1981-03-18

Publications (2)

Publication Number Publication Date
ES8503677A1 true ES8503677A1 (es) 1985-03-16
ES522869A0 ES522869A0 (es) 1985-03-16

Family

ID=4219779

Family Applications (8)

Application Number Title Priority Date Filing Date
ES510504A Expired ES8400102A1 (es) 1981-03-18 1982-03-17 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES522868A Expired ES8502980A1 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982)
ES522867A Granted ES522867A0 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982)
ES522869A Granted ES522869A0 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982).
ES537278A Granted ES537278A0 (es) 1981-03-18 1984-10-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES537277A Granted ES537277A0 (es) 1981-03-18 1984-10-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES537342A Expired ES8604180A1 (es) 1981-03-18 1984-11-02 Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos
ES537343A Granted ES537343A0 (es) 1981-03-18 1984-11-02 Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES510504A Expired ES8400102A1 (es) 1981-03-18 1982-03-17 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES522868A Expired ES8502980A1 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982)
ES522867A Granted ES522867A0 (es) 1981-03-18 1983-05-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos. (como desglose y con prioridad de la patente espanola no.510.504, presentada el 17 de marzo de 1.982)

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES537278A Granted ES537278A0 (es) 1981-03-18 1984-10-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES537277A Granted ES537277A0 (es) 1981-03-18 1984-10-31 Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
ES537342A Expired ES8604180A1 (es) 1981-03-18 1984-11-02 Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos
ES537343A Granted ES537343A0 (es) 1981-03-18 1984-11-02 Procedimiento para la obtencion de azoles 2, 4, 5-trisustituidos

Country Status (16)

Country Link
US (1) US4451471A (es)
EP (1) EP0061425A3 (es)
JP (1) JPS57183767A (es)
KR (1) KR830009066A (es)
AU (1) AU8166782A (es)
DK (1) DK118482A (es)
ES (8) ES8400102A1 (es)
FI (1) FI820877L (es)
GB (1) GB2098203B (es)
GR (1) GR78347B (es)
HU (1) HU187684B (es)
IL (1) IL65285A (es)
NO (1) NO820881L (es)
NZ (1) NZ200038A (es)
PT (1) PT74593B (es)
ZA (1) ZA821790B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632930A (en) * 1984-11-30 1986-12-30 E. I. Du Pont De Nemours And Company Antihypertensive alkyl-arylimidazole, thiazole and oxazole derivatives
DE3508666A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische disulfide und ihre anwendung als immunmodulatoren
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
JPS6339868A (ja) * 1986-08-04 1988-02-20 Otsuka Pharmaceut Factory Inc ジ低級アルキルフエノ−ル誘導体
EP0301613B1 (en) * 1987-07-27 1991-07-10 Duphar International Research B.V Thiazole compounds having fungicidal activity
AT392788B (de) * 1988-02-03 1991-06-10 Fisons Plc Neue benzimidazolverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE3807232A1 (de) * 1988-03-05 1989-09-14 Bayer Ag Substituierte acrylsaeureester
JP2933739B2 (ja) * 1990-04-09 1999-08-16 明治製菓株式会社 チアゾールまたはイミダゾール誘導体および抗潰瘍剤
US5255697A (en) * 1991-10-23 1993-10-26 Working Inc. Walking support apparatus
JP2636819B2 (ja) 1994-12-20 1997-07-30 日本たばこ産業株式会社 オキサゾール系複素環式芳香族化合物
CA2381215A1 (en) * 1999-08-06 2001-02-15 Takeda Chemical Industries, Ltd. P38map kinase inhibitors
BRPI0706621A2 (pt) * 2006-01-18 2011-04-05 Amgen Inc composto, composição farmacêutica, métodos para tratar um distúrbio mediado por quinase em um mamìfero e para tratar um distúrbio relacionado com a proliferação em um mamìfero, e , uso do composto
US7919504B2 (en) * 2007-07-17 2011-04-05 Amgen Inc. Thiadiazole modulators of PKB
IN2015DN00202A (es) 2012-07-12 2015-06-12 Chiesi Farma Spa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
FR2146161A1 (en) * 1971-07-22 1973-03-02 Roussel Uclaf Thiazolyl thiolacetic acids - analgesics antiinflammatories and antipyretics
US3888870A (en) * 1974-03-08 1975-06-10 Sandoz Ag 2-sulfinyl-thiazoles and oxazoles
US4022607A (en) * 1975-06-09 1977-05-10 Sandoz, Inc. Substituted oxazoles and thiazoles as herbicides

Also Published As

Publication number Publication date
HU187684B (en) 1986-02-28
PT74593A (de) 1982-04-01
ES510504A0 (es) 1983-10-16
NO820881L (no) 1982-09-20
ZA821790B (en) 1983-01-26
AU8166782A (en) 1982-09-23
ES8601171A1 (es) 1985-10-16
ES522868A0 (es) 1985-02-01
ES537342A0 (es) 1986-01-16
ES8603847A1 (es) 1986-01-01
IL65285A (en) 1985-11-29
EP0061425A2 (de) 1982-09-29
GB2098203A (en) 1982-11-17
GR78347B (es) 1984-09-26
ES8603499A1 (es) 1985-12-16
ES537278A0 (es) 1985-12-16
NZ200038A (en) 1985-05-31
IL65285A0 (en) 1982-05-31
ES8604180A1 (es) 1986-01-16
GB2098203B (en) 1985-05-09
KR830009066A (ko) 1983-12-17
EP0061425A3 (de) 1982-12-15
DK118482A (da) 1982-09-19
ES522869A0 (es) 1985-03-16
ES537343A0 (es) 1985-10-16
US4451471A (en) 1984-05-29
ES537277A0 (es) 1986-01-01
PT74593B (de) 1984-11-27
ES8400102A1 (es) 1983-10-16
JPS57183767A (en) 1982-11-12
ES8502980A1 (es) 1985-02-01
FI820877L (fi) 1982-09-19
ES8603498A1 (es) 1985-12-16
ES522867A0 (es) 1985-12-16

Similar Documents

Publication Publication Date Title
ES8400102A1 (es) Procedimiento para la obtencion de azoles 2,4,5-trisustituidos.
DK623586D0 (da) Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
DE3173080D1 (en) Pyrimidine-2-sulphides and their s-oxides for use in medicine, pharmaceutical compositions containing them, processes for their preparation and such compounds when novel per se
IL49411A (en) Phenylalkyl-carboxylic acid derivatives processes for the preperation thereof and pharmaceutical compositions containing the same
IL69056A0 (en) Ketenethioacetal derivatives,their preparation and pharmaceutical compositions containing them
DK361587D0 (da) Thiazolyleddikesyrederivater og fremgangsmaader til fremstilling deraf
ES8403887A1 (es) Procedimiento de obtencion de los 2-amino 5- (aralcoil piperidino alcoil) amino 1,4-diazoles
ES8105328A1 (es) Procedimiento para la obtencion de compuestos de acido ami- notiazolacetamido-3-cefem-4-carboxilico
FI873892A0 (fi) Nya derivat av dihydro-oxazol, foerfarande foer deras framstaellning och deras anvaendning.
ES471770A1 (es) Procedimiento para la obtencion de compuestos de b-lactama
FR2663029B1 (fr) Derives de benzothiazole, leur preparation et les medicaments les contenant.
ES8800191A1 (es) Procedimiento para preparar nuevas flavonas y tioflavonas
IL59358A (en) Hydroxytetrahydro(phenoxymethyl)-imidazothiazole and thiazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
JPS55141484A (en) Pyridazine derivative